Clinical Trial Update: Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support [EARLY_Phase 1]

View source ↗

Summary

A Phase Early Phase 1 study is evaluating sildenafil to reduce vascular remodeling in patients supported with a left ventricular assist device, and the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Vascular Diseases | EARLY_Phase 1 | Status: RECRUITING